Yahoo · Oct 19, 2026
Is Exponent (EXPO) Stock Outpacing Its Business Services Peers This Year?
Here is how Exponent (EXPO) and NTT (NTTYY) have performed compared to their sector so far this year.
EX
NASDAQ · EXPO
Exponent, Inc.
Industrials · Consulting Services
$80.26
Up+$1.95 (+2.49%)
Updated Nov 1, 2026, 6:47 AM
SID Score
6.9/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.67B
- P/E ratio
- 35.82
- Dividend yield
- 1.50%
- 52-week range
- $51.91 – $83.18
- Volume
- 773.55K
- Avg. volume
- 408.27K
Price performance · EXPO
EXPO price history
1M range · 0 trading sessions · Daily adjusted prices
EXPO does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest EXPO news
The latest Smart Investors Daily articles mentioning EXPO.
Stock researchCompany · Overview
Company
Market Activity
Research & News
EXPO research
Overview
Company profile and research snapshot.
Company profile
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $104.00
- Implied upside
- —
- Analysts
- 9
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 31, 2026 | JP Morgan | Overweight | — |
| Jul 31, 2026 | UBS | Neutral | — |
| May 15, 2026 | JP Morgan | Overweight | — |
| May 1, 2026 | UBS | Neutral | — |
| Mar 26, 2026 | JP Morgan | Overweight | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 18, 2026
3 Quality Stocks With ROE Over 30%
Interest payments on US government debt now cost about US$3b a day, which concentrates attention on balance sheet strength wherever you invest. When public finances look stretched, investors often care more about companies that generate solid returns on shareholder capital and keep their own debt under control. This article highlights three stocks that combine high return on equity, resilient historic execution and clean finances from our strong balance sheet screen. The three examples in...
Yahoo · Oct 10, 2026
Exponent (EXPO) Stock Looks Reasonable Against Its Cash Flow Value
Exponent has had a mixed share price journey in recent years, and that uneven path puts the spotlight squarely on whether the current US$69.81 price is supported by the cash the business can generate. With a Discounted Cash Flow (DCF) intrinsic value estimate available, the question is how closely that market tag lines up with the cash flow outlook investors are effectively paying for today. Over the past 5 years the stock has declined 32.9%, which makes the gap between long term share...
Yahoo · Oct 8, 2026
Exponent to Announce Third Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on October 29, 2026
MENLO PARK, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report third quarter of fiscal year 2026 financial results for the period ended October 2, 2026 following the close of the market on Thursday, October 29, 2026. On that day, Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson, will host a conference call and webcast at 4:30 p.m. ET (
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
